These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26998103)

  • 1. Successful treatment of Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient using 3,4-diaminopyridine: A case report.
    Hyun JW; Kim SH; Jeong IH; Kim HT; Kim HJ
    Oncol Lett; 2016 Mar; 11(3):1933-1935. PubMed ID: 26998103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
    Schoser B; Eymard B; Datt J; Mantegazza R
    J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amifampridine to treat Lambert-Eaton myasthenic syndrome.
    Oh SJ
    Drugs Today (Barc); 2020 Oct; 56(10):623-641. PubMed ID: 33185628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment.
    Quartel A; Turbeville S; Lounsbury D
    Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.
    Lindquist S; Stangel M
    Neuropsychiatr Dis Treat; 2011; 7():341-9. PubMed ID: 21822385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambert-Eaton Myasthenic Syndrome.
    Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
    Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative care for a patient with Lambert-Eaton myasthenic syndrome: role of 3,4-diaminopyridine.
    Chan KY; Chang RS; Lau VW; Chan ML; Lai T
    Ann Palliat Med; 2016 Oct; 5(4):311-314. PubMed ID: 27506750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amifampridines are the Most Effective Drugs for Treating Lambert-Eaton Myasthenic Syndrome With a Focus on Pediatric Lambert-Eaton Myasthenic Syndrome.
    Oh SJ
    J Clin Neurol; 2024 Jul; 20(4):353-361. PubMed ID: 38951970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
    Wirtz PW; Titulaer MJ; Gerven JM; Verschuuren JJ
    Expert Rev Clin Immunol; 2010 Nov; 6(6):867-74. PubMed ID: 20979551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
    Meriney SD; Tarr TB; Ojala KS; Wu M; Li Y; Lacomis D; Garcia-Ocaña A; Liang M; Valdomir G; Wipf P
    Ann N Y Acad Sci; 2018 Jan; 1412(1):73-81. PubMed ID: 29125190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
    Tarr TB; Lacomis D; Reddel SW; Liang M; Valdomir G; Frasso M; Wipf P; Meriney SD
    J Physiol; 2014 Aug; 592(16):3687-96. PubMed ID: 25015919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifampridine tablets for the treatment of Lambert-Eaton myasthenic syndrome.
    Mantegazza R
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1013-1018. PubMed ID: 31639317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage gated calcium channel antibody-related neurological diseases.
    Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
    World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
    Hülsbrink R; Hashemolhosseini S
    Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.
    Tarr TB; Wipf P; Meriney SD
    Mol Neurobiol; 2015 Aug; 52(1):456-63. PubMed ID: 25195700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
    Motomura M; Iwanaga H
    Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.